Thierry Lecomte

14.5k total citations · 2 hit papers
254 papers, 6.5k citations indexed

About

Thierry Lecomte is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Thierry Lecomte has authored 254 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Oncology, 81 papers in Pulmonary and Respiratory Medicine and 63 papers in Surgery. Recurrent topics in Thierry Lecomte's work include Colorectal Cancer Treatments and Studies (64 papers), Gastric Cancer Management and Outcomes (48 papers) and Pancreatic and Hepatic Oncology Research (43 papers). Thierry Lecomte is often cited by papers focused on Colorectal Cancer Treatments and Studies (64 papers), Gastric Cancer Management and Outcomes (48 papers) and Pancreatic and Hepatic Oncology Research (43 papers). Thierry Lecomte collaborates with scholars based in France, United States and Canada. Thierry Lecomte's co-authors include Pierre Laurent‐Puig, Bruno Landi, Philippe Beaune, Alexandre Dufour, Jean‐Christophe Olivo‐Marín, Thomas Provoost, Nicolas Hervé, Thibault Lagache, Nicolas Chenouard and Fabrice de Chaumont and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Thierry Lecomte

232 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Icy: an open bioimage informatics platform for extended reproducible research

2012 1.0k citations Thierry Lecomte et al. profile →
Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

2009 529 citations Pierre Laurent‐Puig, Anne Cayre et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Thierry Lecomte

Since Specialization

Citations

This map shows the geographic impact of Thierry Lecomte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lecomte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lecomte more than expected).

Fields of papers citing papers by Thierry Lecomte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lecomte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lecomte. The network helps show where Thierry Lecomte may publish in the future.

Co-authorship network of co-authors of Thierry Lecomte

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Lecomte. A scholar is included among the top collaborators of Thierry Lecomte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Lecomte. Thierry Lecomte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adverse childhood experiences, social functioning deficits and comorbid clinical symptoms among individuals with psychotic disorders: A prospective cohort study 2025 ·Schizophrenia Research ·(unknown), Isabelle Daigneault, Charles‐Édouard Giguère, Thierry Lecomte	0
2	PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma 2025 ·Journal of Clinical Oncology ·Michel Ducreux, (unknown), Yves Rinaldi, Frédéric Di Fiore, Rosine Guimbaud, Ludovic Evesque, Jean‐Baptiste Bachet, (unknown), Thierry Lecomte, Olivier Capitain, Aurélie Parzy, (unknown), Pierre-Luc Etienne, Julien Forestier, Farid El Hajbi, (unknown), Valérie Lebrun-Ly, (unknown), Matthieu Texier, Olivier Bouché	3
3	Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Network 2024 ·Journal of Nuclear Medicine ·(unknown), Louis de Mestier, Magalie Haissaguerre, Pauline Afchain, Julien Hadoux, Thierry Lecomte, David Morland, Anne‐Ségolène Cottereau, (unknown), (unknown), Jérémie Tordo, M. Janier, (unknown), Thomas Walter	8
4	517P Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: The RASINTRO prospective multicenter study 2024 ·Annals of Oncology ·(unknown), (unknown), (unknown), Aurélia Meurisse, Pascal Artru, Thierry Lecomte, (unknown), Romain Coriat, (unknown), Romain Cohen, (unknown), Samy Louafi, Jean‐Baptiste Bachet, Julien Taı̈eb, Déwi Vernerey, (unknown), Pierre Laurent‐Puig	1
5	FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer—A Multicenter Prospective Study 2024 ·Journal of Clinical Oncology ·Mathilde Cancel, (unknown), (unknown), (unknown), Thierry Lecomte, (unknown), Pierre Combe, (unknown), (unknown), (unknown), (unknown), Étienne Dorval	7
6	A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort 2024 ·ESMO Open ·Gaël S. Roth, Anna Pellat, Guillaume Piessen, Karine Le Malicot, (unknown), (unknown), David Tougeron, Vincent Hautefeuille, Marine Jary, (unknown), Morgane Amil, (unknown), Marie Müller, Thierry Lecomte, Marielle Guillet, (unknown), Claire Genet, (unknown), Olivier Bouché, Julien Taı̈eb	0
7	Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer 2024 ·Digestive and Liver Disease ·(unknown), Morgane Caulet, Olivier Bouché, Christophe Borg, Sylvain Manfrédi, Olivier Capitain, Jean‐Philippe Spano, William Raoul, Maxime Guéguinou, Olivier Hérault, Aurélie Ferru, (unknown), Olivier Sire, Thierry Lecomte	1
8	LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network 2023 ·Annals of Oncology ·Thomas Walter, Thierry Lecomte, Julien Hadoux, Patricia Niccoli, (unknown), (unknown), Rosine Guimbaud, Mathieu Baconnier, Vincent Hautefeuille, Christine Do Cao, Caroline Pétorin, (unknown), Marine Perrier, Thomas Aparicio, J-Y. Scoazec, C. Lombard Bohas, Sylvie Bin, Valérie Hervieu, Marc Barritault, (unknown)	5
9	Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study 2022 ·International Journal of Cancer ·(unknown), Vincent Hautefeuille, Louis de Mestier, Clélia Coutzac, Thierry Lecomte, (unknown), Pascal Artru, Anthony Turpin, Antoine Drouillard, David Malka, My‐Linh Tran‐Minh, Isabelle Trouilloud, Astrid Lièvre, Nicolas Williet, Simon Pernot, Yann Touchefeu, Julien Taı̈eb, Pascal Hammel, Aziz Zaanan	2
10	Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial – Prodige 31 REMINET: An FFCD study 2022 ·European Journal of Cancer ·Côme Lepage, (unknown), Astrid Lièvre, (unknown), Laëtitia Dahan, David Tougeron, Christos Toumpanakis, (unknown), Catherine Lombard‐Bohas, Ivan Borbath, Romain Coriat, Thierry Lecomte, Rosine Guimbaud, Caroline Pétorin, Jean-Louis Legoux, Pierre Michel, J.Y. Scoazec, Denis Smith, Thomas Walter	13
11	Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials 2021 ·European Journal of Cancer ·(unknown), Thomas Aparicio, Karine Le Malicot, Michel Ducreux, Thierry Lecomte, Jean‐Baptiste Bachet, Julien Taı̈eb, Jean-Louis Legoux, Aimery de Gramont, Jaafar Bennouna, Olivier Bouché, (unknown), Sylvain Manfrédi, Jean‐Marc Gornet	4
12	A Robust Enzyme-Linked Immunosorbent Assay to Measure Serum Ramucirumab Concentrations 2021 ·Bioanalysis ·Céline Desvignes, David Ternant, Thierry Lecomte, Astrid Lièvre, Marc Ohresser, (unknown), William Raoul, Gilles Paintaud	2
13	Molecular description of ANGPT2 associated colorectal carcinoma 2020 ·International Journal of Cancer ·Marine Jary, (unknown), Angélique Vienot, (unknown), Romain Loyon, (unknown), Adeline Bouard, (unknown), (unknown), Stéfano Kim, (unknown), (unknown), Olivier Adotévi, Olivier Bouché, Thierry Lecomte, Christophe Borg, Jean Paul Feugeas	22
14	Cross-Cultural Adaptation and Psychometric Validation of the French Version of the FAMCARE-Patient (FFP-16) Questionnaire for Outpatients With Advanced-Stage Cancer 2020 ·Journal of Pain and Symptom Management ·(unknown), Thomas Flament, Thierry Lecomte, (unknown), (unknown), Éric Pichon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jean-Benoît Hardouin	1
15	Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study 2019 ·European Journal of Cancer ·Claire Gallois, Pascal Artru, Astrid Lièvre, Édouard Auclin, Thierry Lecomte, Christophe Locher, Lysiane Marthey, (unknown), Roger Faroux, Simon Pernot, Maximilien Barret, Julien Taı̈eb	28
16	Prognostic Value of Angiopoietin-2 for Death Risk Stratification in Patients with Metastatic Colorectal Carcinoma 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Marine Jary, Déwi Vernerey, Thierry Lecomte, Erion Dobi, François Ghiringhelli, Franck Monnien, Yann Godet, Stéfano Kim, Olivier Bouché, Serge Fratté, Anthony Gonçalvès, Julie Léger, (unknown), Olivier Adotévi, Franck Bonnetain, Christophe Borg	16
17	Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma 2015 ·Medicine ·Bertrand Brieau, Céline Lepère, Thomas Walter, Thierry Lecomte, Rosine Guimbaud, Sylvain Manfrédi, David Tougeron, Françoise Desseigne, Nelson Lourenço, Pauline Afchain, Farid El Hajbi, Benoît Terris, Philippe Rougier, Romain Coriat	24
18	Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients 2013 ·Journal of Clinical Oncology ·Thomas Aparicio, Jean–Louis Jouve, Laurent Teillet, D. Gargot, Fabien Subtil, Valérie Le Brun-Ly, Jacques Cretin, Christophe Locher, Olivier Bouché, Gilles Breysacher, J Charneau, Jean‐François Seitz, Mohamed Gasmi, Laëtitia Stefani, Mohamed Ramdani, Thierry Lecomte, Emmanuel Mitry	154
19	Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer breakdown → 2009 ·Journal of Clinical Oncology ·Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau, Emmanuel Buc, Jean‐Baptiste Bachet, Thierry Lecomte, Philippe Rougier, Astrid Lièvre, Bruno Landi, Valérie Boige, Michel Ducreux, Marc Ychou, Frédéric Bibeau, Olivier Bouché, Julia Reid, Steven Stone, Frédérique Penault‐Llorca	529
20	An Enzyme-Linked Immunosorbent Assay for Therapeutic Drug Monitoring of Cetuximab 2009 ·Therapeutic Drug Monitoring ·(unknown), David Ternant, (unknown), Danielle Degenne, Nicolas Azzopardi, Étienne Dorval, Hervé Watier, Thierry Lecomte, Gilles Paintaud	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact